Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVS | Common Stock | Sale | -$796K | -9.48K | -6.15% | $84.00 | 145K | May 7, 2021 | Direct | F1 |
holding | CVS | Common Stock (restricted) | 4.81K | May 7, 2021 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | CVS | Stock Option | 47.9K | May 7, 2021 | Common Stock | 47.9K | $102.26 | Direct | F2 | |||||
holding | CVS | Stock Option | 53.8K | May 7, 2021 | Common Stock | 53.8K | $104.82 | Direct | F3 | |||||
holding | CVS | Stock Option | 75.1K | May 7, 2021 | Common Stock | 75.1K | $78.05 | Direct | F4 | |||||
holding | CVS | Stock Option | 87.6K | May 7, 2021 | Common Stock | 87.6K | $62.21 | Direct | F5 | |||||
holding | CVS | Stock Option | 162K | May 7, 2021 | Common Stock | 162K | $54.19 | Direct | F6 | |||||
holding | CVS | Stock Option | 113K | May 7, 2021 | Common Stock | 113K | $58.34 | Direct | F7, F8 | |||||
holding | CVS | Stock Option | 99.3K | May 7, 2021 | Common Stock | 99.3K | $74.30 | Direct | F9 |
Id | Content |
---|---|
F1 | All sales were effected pursuant to a Rule 10b5-1 plan. |
F2 | Option became exercisable in four equal annual installments, commencing 4/1/2016. |
F3 | Option became exercisable in four equal annual installments, commencing 4/1/2017. |
F4 | Option became exercisable in four equal annual installments, commencing 4/3/2018. |
F5 | Option became exercisable in four equal annual installments, commencing 4/1/2019. |
F6 | Option became exercisable in four equal annual installments, commencing 4/1/2020. |
F7 | The number of shares subject to the option were calculated using a 30-day average price. |
F8 | Options became exercisable in four equal annual installments, commencing 4/1/2021. |
F9 | Option becomes exercisable in four equal annual installments, commencing 4/1/2022. |